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Neurological Manifestations of Myeloneuropathy in Patients 
with Nitrous Oxide Intoxication
Dear Editor, 
Nitrous oxide (N2O) is a long-standing anesthetic that also exhibits neurotoxicity by in-
terfering with the bioavailability of vitamin B12. The euphorigenic effects of N2O result in it 
often being abused by adolescents. Various neurological manifestations have been described 
for the neurotoxicity of N2O, such as myelopathy, peripheral neuropathy, and subacute com-
bined degeneration.1 Psychiatric disorder and medical sequelae also have been reported.2 
Four patients with progressive limb paralysis after recreationally inhaling N2O were ad-
mitted to the neuromuscular clinic. All of the patients were women, were aged 21–36 years, 
had abused N2O for between 1 and 5 months, and exhibited some degree of motor weak-
ness in the lower extremities. Sensory examinations revealed paresthesia in three of the four 
patients. Patient 1 had no sensory deficit and described a tingling sensation, while Patient 3 
reported burning pain. Two patients (Patients 2 and 3) had decreased positional and vibra-
tion senses, and a positive Romberg’s sign. In addition to the neurological deficit, Patient 4 
showed psychiatric symptoms such as irritability, agitation, reduced sleep, delusions of refer-
ences (i.e., thinking that others were doubting her), and anxiety. Patient 4 was also diagnosed 
with incidental pulmonary thromboembolisms with lung infarctions. Serological tests indi-
cated the absence of anemia in Patients 1, 2, and 3, but an increased mean corpuscular vol-
ume, while Patient 4 showed moderate anemia with macrocytosis. The vitamin B12 level was 
low and the homocysteine level was high in all patients. Cerebrospinal fluid analysis showed 
normal protein and cell counts in all patients. In nerve conduction studies, two patients 
(Patients 1 and 2) presented with demyelinating polyneuropathy, one (Patient 4) with axo-
nal polyneuropathy, and one (Patient 3) without neuropathy. Median and posterior tibial 
somatosensory evoked potential tests demonstrated central conduction defects in three pa-
tients (Patients 1, 2, and 3). Spinal MRI showed high T2-weighted signals in the posterior 
column in three of the patients (Patients 1, 2, and 3) (Fig. 1). However, Patient 4, who ini-
tially had normal spine MRI findings, continued to inhale N2O gas, and follow-up MRI 
showed high T2-weighted signals in the posterior column (Fig. 1I and J). 
For treatment, intramuscular vitamin B12 was administered to all patients. Patient 1 addi-
tionally received intravenous immunoglobulin therapy for 5 days to address the superimposed 
Guillain-Barré syndrome. Patient 4 received a direct oral anticoagulant (apixaban, 5 mg bid) 
due to pulmonary thromboembolisms. 
Neuropathy induced by N2O has various clinical and neurophysiological manifestations.1 
Some neurophysiological studies of N2O-induced peripheral neuropathy have predominant-
ly found axonal neuropathy,3 while others showed demyelinating neuropathy.4 The clinical 
manifestations in our patients could be classified into two categories: myelopathy with periph-
eral neuropathy (Patients 1, 2, and 4) and myelopathy without peripheral neuropathy (Patient 
3). The neurophysiological studies applied to our patients revealed different patterns: Patients 
1 and 2 showed demyelinating-type polyneuropathy, and Patient 4 showed sensory-dominant 
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axonal neuropathy that progressed to motor-dominant poly-
neuropathy. 
N2O increases the homocysteine level, which increases the 
risk of thrombosis.5 Patient 4 did not have any symptoms or 
signs of a pulmonary embolism, but this was detected inciden-
tally in spinal MRI and represents a rare case of incidental pul-
monary thromboembolism due to N2O abuse.
In conclusion, N2O abuse can cause various clinical and neu-
rophysiological manifestations of myeloneuropathy along 
with psychiatric and medical sequelae. The difficulty of ascer-
taining the presence of N2O abuse and its various clinical fea-
tures mean that clinicians should not exclude the possibility of 
N2O toxicity in the differential diagnosis when examining pa-
tients with ascending paralysis.
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Fig. 1. Findings of axial and sagittal T2-weighted MRI of the cervical 
spinal cord in all four patients. Patient 1 showed (A) suspicious demy-
elination within the dorsal columns in an axial view and (B) suspicious 
demyelination of C2–C5 in a sagittal view. Patient 2 showed (C) demy-
elination within the dorsal columns in an axial view and (D) demyelin-
ation of C1–C5 in a sagittal view. Patient 3 showed (E) demyelination 
within the dorsal columns in an axial view and (F) demyelination of 
C1–C7 in a sagittal view. Patient 4 initially showed (G and H) no ab-
normal hyperintensities, but 3-month follow-up MRI showed (I) de-
myelination within the dorsal columns in an axial view and (J) demye-
lination of C1–C6 in a sagittal view.
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